Does the Emerson Electric stock out of Dow?

Saint Louis, Emerson Electric Co. With a market of $ 72.9 billion, Emerson operates through final control, measurement, analyzes, separate automation, safety, productivity, control, programs, testing and measurement experiences.

Companies of $ 10 billion or more are described as “large shares”. Emr fits this bill completely. Given the operations of the company’s vast and dominant company in the industrial sector, its evaluation above this sign is not surprising.

Emerson touched its highest level ever at $ 150.27 on July 29, and is currently trading at 11.4 % less than that peak. Meanwhile, over the past three months, Emerson stock prices have increased by 9.5 %, with Dow Jones Industrial MEVERGAL ($ DowI) gained by 7.5 % during the same time frame.

In the long run, Emerson’s performance appears more impressive. EMR shares gained 7.4 % based on YTD and rose 32 % over the past 52 weeks, exceeding 72 % of Dow in 2025 and 11.3 % over the past year.

To confirm the upward trend and the last shrinkage, EMR has been constantly trading higher than the moving average for 200 days since early May and decreased to less than the moving average for 50 days in early August.

Emerson Electric shares prices decreased by 4.7 % after the release of mixed Q3 results on August 6. The decrease in the first place can be attributed to the net sales of Emerson of $ 4.6 billion in the loss of street expectations by 60 basis points. However, the sales number increased by 4 % on almost annually, and the company’s general performance remained flexible. The quarter was distinguished with strong profitability and cash flows despite the chaotic overall environment. The profitability of the EMERSON modified stock increased by 6.3 % year on an annual basis to $ 1.52, bypassing unanimity estimates by 66 basis points. Moreover, the company produced solid free cash flows of $ 970 million in a quarter.

Meanwhile, Emerson had led to a slight weakness in increasing peers, RockWell Automation, Inc. (ROK) by 33.2 % over 52 weeks and 19.6 % in 2025.

Among the 25 analysts covering EMR, the category of consensus is “moderate purchase”. The average target price means $ 150.46 to up to up the upscale capabilities of 13 % of the current price levels.

On the date of publication, Aditya Sarawi did not have positions (either directly or indirectly) in any of the securities mentioned in this article. All information and data in this article are only for media purposes. This article was originally published on Barchart.com